Drugs / OXA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05239650 | Jul 2022 → Oct 2025 overdue | — | Shanghai Henlius Biotech | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OXA | “OXA：85 mg/m2” NCT05239650 ↗ |